Sale!

ACTC1 Gene Cardiomyopathy Familial Hypertrophic Type 11 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The ACTC1 Gene Cardiomyopathy Familial Hypertrophic Type 11 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the ACTC1 gene associated with familial hypertrophic cardiomyopathy. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variants that can cause abnormal thickening of the heart muscle, potentially leading to serious cardiac complications. The test is particularly valuable for individuals with family history of sudden cardiac death, unexplained heart conditions, or those experiencing symptoms like chest pain, shortness of breath, or palpitations. Early detection through this $500 USD test enables proactive management strategies, personalized treatment plans, and informed family planning decisions. Our nationwide testing centers provide accessible cardiac genetic screening with professional genetic counseling support.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ACTC1 Gene Cardiomyopathy Familial Hypertrophic Type 11 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Heart Conditions

The ACTC1 Gene Cardiomyopathy Familial Hypertrophic Type 11 NGS Genetic DNA Test represents a breakthrough in cardiac genetic diagnostics, offering precise detection of mutations responsible for familial hypertrophic cardiomyopathy. This specialized test examines the ACTC1 gene, which encodes cardiac alpha-actin, a crucial protein component of the heart muscle’s contractile apparatus. Mutations in this gene can disrupt normal cardiac function and lead to progressive heart muscle thickening, potentially causing life-threatening complications if left undetected.

What Does This Test Measure and Detect?

Our advanced NGS-based genetic analysis specifically targets:

  • Pathogenic variants in the ACTC1 gene associated with familial hypertrophic cardiomyopathy type 11
  • Single nucleotide polymorphisms (SNPs) affecting cardiac muscle protein structure
  • Genetic mutations that disrupt actin filament assembly in heart muscle cells
  • Inherited variants that may cause abnormal ventricular wall thickening
  • Genetic markers linked to increased risk of arrhythmias and sudden cardiac death

Who Should Consider This Genetic Test?

This comprehensive cardiac genetic screening is recommended for individuals experiencing:

  • Unexplained chest pain or discomfort during physical activity
  • Family history of sudden cardiac death or unexplained cardiac events
  • Recurrent palpitations, dizziness, or fainting episodes
  • Abnormal heart sounds detected during physical examinations
  • Relatives diagnosed with hypertrophic cardiomyopathy
  • Unexplained shortness of breath during routine activities
  • Abnormal electrocardiogram (ECG) findings suggestive of cardiac hypertrophy

Significant Benefits of Early Genetic Detection

Undergoing the ACTC1 genetic test provides numerous advantages:

  • Early Intervention Opportunities: Identify genetic risk factors before symptom onset
  • Personalized Treatment Planning: Develop targeted management strategies based on genetic profile
  • Family Risk Assessment: Enable genetic counseling for at-risk family members
  • Informed Lifestyle Decisions: Make educated choices about physical activity and career paths
  • Reproductive Planning: Understand inheritance patterns for family planning decisions
  • Peace of Mind: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret results effectively:

  • Positive Result: Indicates presence of ACTC1 mutation; requires cardiology follow-up and family screening
  • Negative Result: No detected mutation; regular cardiac monitoring may still be recommended
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Professional Guidance: All results include detailed explanation and management recommendations

Test Pricing and Availability

Test Feature Details
Test Name ACTC1 Gene Cardiomyopathy Familial Hypertrophic Type 11 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood
Testing Method Next-Generation Sequencing (NGS)

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible cardiac genetic testing for patients nationwide.

Take Control of Your Cardiac Health Today

Don’t wait to understand your genetic cardiac risk profile. Our expert team of genetic counselors and cardiology specialists are ready to guide you through the testing process and provide comprehensive support for result interpretation and management planning.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your ACTC1 genetic test consultation and take the first step toward proactive cardiac health management.

Early genetic detection through the ACTC1 Gene Cardiomyopathy Test can provide life-saving insights and enable personalized preventive strategies for you and your family members at risk for inherited heart conditions.